Cannapharmarx, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
CannaPharmaRx, a Canadian cannabis cultivator, reported a widened net loss of $11.1 million for 2025 and faces substantial doubt about its ability to continue as a going concern.
OTC.Pink
CannaPharmaRx's 10-K filing reveals a net loss of $9.9 million for 2024, despite generating $820,137 in revenue for the first time, as the company navigates strategic shifts and operational challenges.
OTC.Pink
10-K: CannaPharmaRX Reports Net Income of $3.7 Million in 2023, Despite Ongoing Going Concern Concerns
CannaPharmaRX reported a net income of $3.7 million for 2023, a significant turnaround from the previous year's loss, but continues to face substantial doubt about its ability to continue as a going concern.